|Hong Kong||Published Application||40056423||03/25/2022||2018-173|
|United States Of America||Published Application||20210317527||10/14/2021||2018-173|
|European Patent Office||Published Application||3844303 A0||07/07/2021||2018-173|
|Patent Cooperation Treaty||Published Application||WO2020046809||03/05/2020||2018-173|
Additional Patent Pending
Class 2 CRISPR-Cas systems are streamlined versions in which a single Cas protein (an effector protein, e.g., a type V Cas effector protein such as Cpf1) bound to RNA is responsible for binding to and cleavage of a targeted sequence. The programmable nature of these minimal systems has facilitated their use as a versatile technology that continues to revolutionize the field of genome manipulation.
Cas12 is an RNA-guided protein that binds and cuts any matching DNA sequence. Binding of the Cas12-CRISPR RNA (crRNA) complex to a matching single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) molecule activates the protein to non-specifically degrade any ssDNA in trans. Cas12a-dependent target binding can be coupled to a reporter molecule to provide a direct readout for DNA detection within a sample. UC Berkeley researchers have developed compositions, systems, and kits having labeled single stranded reporter DNA molecules that provide a sensitive readout for detection of a target DNA.
detecting a target DNA (double stranded or single stranded) in a sample
increased speed and sensitivity of nucleic acid detection